Keywords: strong, ph, iii, data, titan, addiction, implant

Strong Ph III data for Titan's addiction implant

Article | 01 December 2008

Print This

The USA's Titan Pharmaceuticals reported positive data from a Phase III study of Probuphine, a subcutaneous implant designed to deliver ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in